BridgeMD
New treatment option for Major Depressive Episode
Official title The Impact of Coach-guided Risk Communication on the Risk of Major Depression
ClinicalTrials.gov ID: NCT06619366
What this study is testing
- What it's testing
- Depression is a highly prevalent and disabling mental health problem. One way of preventing depression is to stop it before it happens through effective self-management.
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- no MDE at baseline, or full remission for 2 months for those who had a past MDE (see below the question).
- Aged 18 and 65 years.
- At high risk of MDE based on the depression risk calculators (predicted risk of 6.5%+ for males and 11.2%+ for females), which represent the top two...
- Agreement to be contacted for follow-up assessments, and
- no language barriers to English or French
You likely can't join if
- individuals who
- cannot provide informed consent,
- do not agree to be followed,
- cannot communicate in English and French, or
- report suicide behaviors (score \>0 on item 9 of the Patient Health Questionnaire (PHQ-9)).
The study team makes the final eligibility decision.
Where it's taking place
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Halifax, Nova Scotia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.